Uncategorized

Latest Ratings for CMCSA Date Firm Action From To Mar 2022 Truist Securities Downgrades Buy Hold Jan 2022 Barclays Maintains Overweight Jan 2022 Morgan Stanley Maintains Overweight View More Analyst Ratings for CMCSA View the Latest Analyst Ratings read more

Latest Ratings for BMRN Date Firm Action From To Feb 2022 Piper Sandler Maintains Overweight Nov 2021 Credit Suisse Maintains Outperform Nov 2021 Morgan Stanley Maintains Equal-Weight View More Analyst Ratings for BMRN View the Latest Analyst Ratings read more

Latest Ratings for FDS Date Firm Action From To Feb 2022 Morgan Stanley Maintains Underweight Jan 2022 Morgan Stanley Maintains Underweight Dec 2021 Morgan Stanley Maintains Underweight View More Analyst Ratings for FDS View the Latest Analyst Ratings read more

Latest Ratings for VRSK Date Firm Action From To Mar 2022 Raymond James Maintains Outperform Jan 2022 Morgan Stanley Downgrades Overweight Equal-Weight Dec 2021 RBC Capital Maintains Outperform View More Analyst Ratings for VRSK View the Latest Analyst Ratings read more

Latest Ratings for KRYS Date Firm Action From To Mar 2022 Goldman Sachs Maintains Buy Feb 2022 HC Wainwright & Co. Maintains Buy Jan 2022 B of A Securities Initiates Coverage On Buy View More Analyst Ratings for KRYS View the Latest Analyst Ratings read more

read more

read more

read more

With Ripple’s regulatory approval to launch its RLUSD stablecoin, anticipation is mounting about the trajectory of XRP (CRYPTO: XRP) prices following the launch. read more

U.S. defense sector braces for turbulence in 2025, as Goldman downgrades General Dynamics and reiterates bearish outlook on other names. read more